SG Americas Securities’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,780
| Closed | -$113K | – | 3120 |
|
|
2023
Q4 | $113K | Sell |
4,780
-10,669
| -69% | -$252K | ﹤0.01% | 2453 |
|
|
2023
Q3 | $230K | Buy |
+15,449
| New | +$230K | ﹤0.01% | 2037 |
|
|
2022
Q2 | – | Sell |
-10,900
| Closed | -$34K | – | 3229 |
|
|
2022
Q1 | $34K | Sell |
10,900
-7,917
| -42% | -$24.7K | ﹤0.01% | 2519 |
|
|
2021
Q4 | $64K | Sell |
18,817
-27,261
| -59% | -$92.7K | ﹤0.01% | 2844 |
|
|
2021
Q3 | $168K | Buy |
+46,078
| New | +$168K | ﹤0.01% | 3076 |
|
|
2021
Q2 | – | Sell |
-13,919
| Closed | -$63K | – | 2934 |
|
|
2021
Q1 | $63K | Sell |
13,919
-5,959
| -30% | -$27K | ﹤0.01% | 2848 |
|
|
2020
Q4 | $114K | Buy |
+19,878
| New | +$114K | ﹤0.01% | 2620 |
|
|
2020
Q3 | – | Sell |
-37,948
| Closed | -$132K | – | 3046 |
|
|
2020
Q2 | $132K | Buy |
37,948
+11,190
| +42% | +$38.9K | ﹤0.01% | 2758 |
|
|
2020
Q1 | $40K | Buy |
+26,758
| New | +$40K | ﹤0.01% | 2717 |
|
|
2019
Q4 | – | Sell |
-16,612
| Closed | -$85K | – | 2855 |
|
|
2019
Q3 | $85K | Buy |
+16,612
| New | +$85K | ﹤0.01% | 2354 |
|